Lv1
89 积分 2021-07-21 加入
Expert panel perspectives on improving the diagnosis and management of metabolic dysfunction-associated steatohepatitis in Denmark
2天前
已关闭
The use of pharmacotherapies in non-cirrhotic metabolic dysfunction-associated steatohepatitis: a UK expert consensus
2天前
已完结
Clinical trial design, biomarkers and end points in metabolic and alcohol-related liver disease
6天前
已完结
Implementing sustainable liver health in Europe: a second EASL–Lancet Commission
8天前
已完结
The use of pharmacotherapies in non-cirrhotic metabolic dysfunction-associated steatohepatitis: a UK expert consensus
8天前
已完结
From science to public health impact: enacting the recommendations of the EASL-Lancet Commission on liver health in Europe
9天前
已完结
Epidemiology and determinants of obesity in China
14天前
已完结
CONFIDENCE INTERVALS FOR DIRECTLY STANDARDIZED RATES: A METHOD BASED ON THE GAMMA DISTRIBUTION
14天前
已完结
No Adjustments Are Needed for Multiple Comparisons
17天前
已完结
The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis
18天前
已完结
皖公网安备34019202002308
